Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LOW
|
Marshall A Croom
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 17,305 Reduced 21.87% |
$834,101
$48.2 p/Share
|
Apr 04
2014 |
|
LOW
|
Marshall A Croom
EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 13,333 Added 15.07% |
$339,992
$25.5 p/Share
|
Apr 04
2014 |
|
FSLR
|
Mark R Widmar
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 12,830 Reduced 22.54% |
$894,508
$69.72 p/Share
|
Apr 04
2014 |
|
FSLR
|
Mark R Widmar
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 28,146 Added 36.63% |
-
|
Apr 04
2014 |
|
ORCL
|
Thomas Kurian
President-Product Development |
BUY
Exercise of conversion of derivative security
|
Direct | 118,582 Added 43.9% |
$3,524,257
$29.72 p/Share
|
Apr 04
2014 |
|
ORCL
|
Thomas Kurian
President-Product Development |
SELL
Open market or private sale
|
Direct | 118,582 Reduced 78.25% |
$4,790,713
$40.4 p/Share
|
Apr 04
2014 |
|
MRK
|
Bruce N Kuhlik
Exe V-P & Gen Counsel |
SELL
Open market or private sale
|
Direct | 145,225 Reduced 54.38% |
$8,196,499
$56.44 p/Share
|
Apr 04
2014 |
|
MRK
|
Bruce N Kuhlik
Exe V-P & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 145,225 Added 35.22% |
$5,904,848
$40.66 p/Share
|
Apr 04
2014 |
|
KWR
|
Michael F Barry
Director |
BUY
Bona fide gift
|
Indirect | 342 Added 20.01% |
-
|
Apr 03
2014 |
|
KWR
|
Michael F Barry
Director |
SELL
Bona fide gift
|
Direct | 684 Reduced 0.45% |
-
|
Apr 03
2014 |
|
TMUS
|
W Michael Barnes
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 37,500 Added 36.03% |
$108,000
$2.88 p/Share
|
Apr 03
2014 |
|
ORCL
|
Thomas Kurian
President-Product Development |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 92.52% |
$16,267,999
$40.67 p/Share
|
Apr 03
2014 |
|
ORCL
|
Thomas Kurian
President-Product Development |
BUY
Exercise of conversion of derivative security
|
Direct | 400,000 Added 48.06% |
$11,888,000
$29.72 p/Share
|
Apr 03
2014 |
|
COST
|
James P. Murphy
Executive VP |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.31% |
$1,120,000
$112.0 p/Share
|
Apr 03
2014 |
|
ALOT
|
Harold Schofield
Director |
BUY
Small Acquisition
|
Direct | 7 Added 0.12% |
$87
$12.49 p/Share
|
Apr 02
2014 |
|
FCNCA
|
Holding Olivia Britton |
BUY
Bona fide gift
|
Direct | 125 Added 0.1% |
-
|
Apr 02
2014 |
|
FCNCA
|
Carson H Brice |
BUY
Bona fide gift
|
Indirect | 125 Added 22.01% |
-
|
Apr 02
2014 |
|
FCNCA
|
Carson H Brice |
BUY
Bona fide gift
|
Direct | 125 Added 0.12% |
-
|
Apr 02
2014 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
SELL
Bona fide gift
|
Indirect | 375 Reduced 56.31% |
-
|
Apr 02
2014 |
|
NILE
|
Amos Kohn
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 50,252 Reduced 55.84% |
$83,921
$1.67 p/Share
|
Apr 02
2014 |
|
NILE
|
Amos Kohn
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 90,000 Added 66.92% |
$90,900
$1.01 p/Share
|
Apr 02
2014 |
|
LOW
|
Maureen K Ausura
EVP Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct | 123,333 Added 54.36% |
$3,200,491
$25.95 p/Share
|
Apr 02
2014 |
|
LOW
|
Maureen K Ausura
EVP Human Resources |
SELL
Open market or private sale
|
Direct | 146,233 Reduced 64.57% |
$7,264,855
$49.68 p/Share
|
Apr 02
2014 |
|
LOW
|
Gaither M Keener Jr
EVP Legal |
SELL
Bona fide gift
|
Direct | 1,500 Reduced 2.46% |
-
|
Apr 02
2014 |
|
ORCL
|
John F Fowler
EVP, Systems |
SELL
Open market or private sale
|
Direct | 750,000 Reduced 97.4% |
$30,795,001
$41.06 p/Share
|
Apr 02
2014 |
|
ORCL
|
John F Fowler
EVP, Systems |
BUY
Exercise of conversion of derivative security
|
Direct | 750,000 Added 49.34% |
$18,570,000
$24.76 p/Share
|
Apr 02
2014 |
|
ORCL
|
H Raymond Bingham
Director |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 100.0% |
$1,648,800
$41.22 p/Share
|
Apr 02
2014 |
|
ORCL
|
H Raymond Bingham
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 40,000 Added 50.0% |
$779,600
$19.49 p/Share
|
Apr 02
2014 |
|
PEP
|
Brian C Cornell
CEO, PepsiCo Americas Foods |
SELL
Payment of exercise price or tax liability
|
Direct | 6,316 Reduced 2.61% |
$522,270
$82.69 p/Share
|
Apr 02
2014 |
|
LGF-B
|
Wayne Levin
General Counsel and CSO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 75,000 Reduced 30.68% |
$2,093,250
$27.91 p/Share
|
Apr 02
2014 |
|
LGF-B
|
Wayne Levin
General Counsel and CSO |
BUY
Exercise of conversion of derivative security
|
Direct | 75,000 Added 23.48% |
$387,750
$5.17 p/Share
|
Apr 02
2014 |
|
SNPS
|
Alfred Castino
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 7.84% |
-
|
Apr 02
2014 |
|
SNPS
|
Bruce R Chizen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 6.01% |
-
|
Apr 02
2014 |
|
SNPS
|
Deborah A Coleman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 5.7% |
-
|
Apr 02
2014 |
|
SNPS
|
Chrysostomos L Nikias
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 20.42% |
-
|
Apr 02
2014 |
|
SNPS
|
John Schwarz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 8.89% |
-
|
Apr 02
2014 |
|
SNPS
|
Roy Vallee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 5.79% |
-
|
Apr 02
2014 |
|
SNPS
|
Steven Walske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,229 Added 7.87% |
-
|
Apr 02
2014 |
|
CVS
|
Eva C Boratto
EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 17,108 Added 43.57% |
$767,294
$44.85 p/Share
|
Apr 02
2014 |
|
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Open market or private sale
|
Direct | 17,108 Reduced 49.1% |
$1,274,717
$74.51 p/Share
|
Apr 02
2014 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
BUY
Exercise of conversion of derivative security
|
Direct | 19,210 Added 60.14% |
$956,658
$49.8 p/Share
|
Apr 02
2014 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
SELL
Open market or private sale
|
Direct | 19,210 Reduced 73.77% |
$1,421,924
$74.02 p/Share
|
Apr 02
2014 |
|
ADBE
|
David Wadhwani
President, Digital Media |
BUY
Exercise of conversion of derivative security
|
Direct | 22,217 Added 32.0% |
$660,289
$29.72 p/Share
|
Apr 02
2014 |
|
ADBE
|
David Wadhwani
President, Digital Media |
SELL
Open market or private sale
|
Direct | 22,217 Reduced 47.05% |
$1,455,436
$65.51 p/Share
|
Apr 02
2014 |
|
LGF-B
|
Gordon Crawford |
BUY
Grant, award, or other acquisition
|
Direct | 1,172 Added 0.57% |
$30,589
$26.1 p/Share
|
Apr 01
2014 |
|
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct | 8,412 Added 17.71% |
$624,927
$74.29 p/Share
|
Apr 01
2014 |
|
CVS
|
Thomas M Moriarty
EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 10,095 Added 31.89% |
$749,958
$74.29 p/Share
|
Apr 01
2014 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,749 Added 14.89% |
$649,963
$74.29 p/Share
|
Apr 01
2014 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,166 Reduced 14.8% |
$532,362
$74.29 p/Share
|
Apr 01
2014 |
|
CVS
|
J. David Joyner
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 4,038 Added 14.58% |
$299,983
$74.29 p/Share
|
Apr 01
2014 |